A new ISO standard that helps assess the sustainability of products and processes related to bioenergy has a huge potential to tackle climate change, promote energy security and foster sustainable development.
Minneapolis Heart Institute Foundation. Summary: Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, according to new research. Share:
Underlying heart diseases were ischemic cardiomyopathy in 2 patients, arrhythmogenic right ventricular dysplasia in 1 patient, and sudden cardiac death in 1 patient. Heart failure may be a consequence of either nonischemic or ischemic cardiomyopathy. For ICDs, the guidelines suggest implantation for class II or III patients who have an ejection fraction of less than 30%; patients with ischemic cardiomyopathy should be at least 40 days post MI.